Cubist Systematic Strategies’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-250,889
| Closed | -$3.95M | – | 2833 |
|
|
2024
Q1 | $3.95M | Sell |
250,889
-27,496
| -10% | -$433K | 0.02% | 600 |
|
|
2023
Q4 | $4.49M | Buy |
278,385
+58,761
| +27% | +$948K | 0.03% | 499 |
|
|
2023
Q3 | $2.79M | Buy |
+219,624
| New | +$2.79M | 0.02% | 655 |
|
|
2023
Q2 | – | Sell |
-123,486
| Closed | -$1.91M | – | 3175 |
|
|
2023
Q1 | $1.91M | Sell |
123,486
-11,676
| -9% | -$180K | 0.01% | 1146 |
|
|
2022
Q4 | $2.22M | Sell |
135,162
-181,551
| -57% | -$2.98M | 0.01% | 1246 |
|
|
2022
Q3 | $5.86M | Buy |
316,713
+136,570
| +76% | +$2.53M | 0.03% | 701 |
|
|
2022
Q2 | $2.37M | Buy |
180,143
+45,904
| +34% | +$604K | 0.01% | 1425 |
|
|
2022
Q1 | $1.24M | Sell |
134,239
-17,792
| -12% | -$165K | 0.01% | 1864 |
|
|
2021
Q4 | $1.49M | Buy |
152,031
+127,176
| +512% | +$1.24M | 0.01% | 1624 |
|
|
2021
Q3 | $845K | Buy |
24,855
+24,717
| +17,911% | +$840K | 0.01% | 1657 |
|
|
2021
Q2 | $5K | Sell |
138
-7,197
| -98% | -$261K | ﹤0.01% | 2877 |
|
|
2021
Q1 | $329K | Sell |
7,335
-14,369
| -66% | -$644K | ﹤0.01% | 2200 |
|
|
2020
Q4 | $1.24M | Buy |
21,704
+7,852
| +57% | +$448K | 0.02% | 1238 |
|
|
2020
Q3 | $711K | Buy |
13,852
+10,052
| +265% | +$516K | 0.01% | 1535 |
|
|
2020
Q2 | $227K | Sell |
3,800
-14,446
| -79% | -$863K | ﹤0.01% | 1977 |
|
|
2020
Q1 | $751K | Sell |
18,246
-62,705
| -77% | -$2.58M | 0.02% | 1009 |
|
|
2019
Q4 | $5.04M | Buy |
80,951
+79,751
| +6,646% | +$4.96M | 0.09% | 309 |
|
|
2019
Q3 | $41K | Sell |
1,200
-12,363
| -91% | -$422K | ﹤0.01% | 2076 |
|
|
2019
Q2 | $306K | Buy |
13,563
+4,854
| +56% | +$110K | 0.01% | 1788 |
|
|
2019
Q1 | $202K | Sell |
8,709
-12,364
| -59% | -$287K | 0.01% | 1778 |
|
|
2018
Q4 | $442K | Buy |
+21,073
| New | +$442K | 0.02% | 1048 |
|